In the latest trading activity, Cathie Wood's ARK ETFs have made significant moves in the stock market for Tuesday, June 25, 2024. Leading the daily trades with the highest dollar-value, ARK sold a substantial 16,801,072 shares of Ginkgo Bioworks Holdings Inc (NYSE:DNA), totaling approximately $6,152,552 in value. This move indicates a continued reduction in ARK's position in DNA, following a pattern of sales in recent days.
Another notable transaction was ARK's sale of 33,834 shares of NVIDIA Corp (NASDAQ:NVDA), which amounted to $3,996,133. This sale comes amidst a broader market evaluation of the semiconductor industry and may reflect ARK's strategic adjustments to its portfolio.
On the buying side, ARK increased its holdings in Roku Inc (NASDAQ:ROKU) with the purchase of 96,465 shares valued at $5,252,519. This investment aligns with ARK's trend of accumulating Roku stock, showcasing confidence in the streaming device company's growth prospects.
ARK also continued to bolster its position in 10X Genomics Inc (NASDAQ:TXG), buying a total of 254,372 shares, bringing the trade's total dollar value to $5,056,915. This consistent accumulation suggests ARK's positive outlook on the genomics company's potential.
Among other purchases, ARK invested in Arcturus Therapeutics (NASDAQ:ARCT) Holdings Inc (NASDAQ:ARCT) by acquiring 34,037 shares at a value of $930,231. This biotech company has been another recurring interest for ARK's investment strategy.
In smaller-scale transactions, ARK bought shares in companies like ABSI Corp (NASDAQ:ABSI), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Blade Air Mobility Inc (NASDAQ:BLDE), Markforged Holding Corp (NYSE:MKFG), PagerDuty Inc (NYSE:NYSE:PD), and Roblox Corp (NYSE:RBLX). These purchases, although not as significant in value as the aforementioned stocks, highlight ARK's diverse interest in innovative and disruptive companies across various sectors.
On the flip side, ARK continued to divest from Teladoc Health Inc (NYSE:NYSE:TDOC), selling 46,035 shares valued at $476,922, and from Zoom Video Communications Inc (NASDAQ:ZM), parting with 85,035 shares at a total dollar value of $4,915,873. These sales could indicate a strategic shift or a response to the companies' recent performance and future outlook.
Lastly, ARK also trimmed its holdings in Verve Therapeutics Inc (NASDAQ:VERV), selling 8,466 shares for a total of $44,700. This concludes the summary of ARK's daily trades for June 25, 2024, reflecting a strategic blend of both divestments and investments in the ever-evolving tech and biotech landscapes.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.